Enacts the manufacturer disclosure and transparency act
Summary
Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.
Bill status
passed
3 of 5 stages cleared
Introduction
Jan 2023
Committee Review
Jan 2024
Senate Passage
Jan 2024
Assembly Passage
Governor
Introduced Jan 31, 2023
Last action Jan 30, 2024
Floor votes · Senate Jan 30, 2024
How they voted
50–12
Passed · 1 other
Total votes 63
Jan 30, 2024
D
Democratic42
100% Yea
R
Republican21
57% Nay
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
8
Key actions
1
Committee
3
Jan 30, 2024
Committee
REFERRED TO CONSUMER AFFAIRS AND PROTECTION
lower
Jan 30, 2024
Upper · Passed
PASSED SENATE
upper
Jan 3, 2024
Committee
REFERRED TO CONSUMER PROTECTION
upper
Jan 31, 2023
Committee
REFERRED TO CONSUMER PROTECTION
upper
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about S 3518
Scope: NY
Hi! I can help you understand S 3518. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline